GlassScriptPhysician profile
Kenneth Edward Bloom
NPI 1477536068
$1,743.97
in general payments reported to CMS, 2019-2025
15 companies · $94.77 in 2025
The $94.77 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $108 · 2021: $144 · 2022: $578 · 2023: $514 · 2024: $125 · 2025: $94.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.55 | 2021-2023 | Rinvoq |
| Incyte Corporation | $276.51 | 2022-2025 | Opzelura |
| Amgen INC. | $226.82 | 2023 | Otezla |
| Dermira, INC. | $206.05 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $155.77 | 2022-2023 | Sotyktu |
| Janssen Biotech, INC. | $134.61 | 2023-2025 | Tremfya, Simponi Aria, Simponi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $127.54 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $124.98 | 2022 | |
| Ucb, INC. | $30.34 | 2025 | Bimzelx |
| Leo Pharma INC. | $25.07 | 2020-2021 | |
| Galderma Laboratories, L.P. | $22.96 | 2020 | |
| Sun Pharmaceutical Industries INC. | $22.77 | 2025 | |
| Almirall LLC | $22.16 | 2019 | |
| Boston Scientific Corporation | $17.76 | 2024 | |
| Pfizer INC. | $17.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.